Interestingly, three components of the complement system, namely C3, C1R, and CFB, also showed a significant upregulation after interaction with the metastatic cell line MDA-MB231 and two of them (C3 and C1R) could be validated in the prostate cancer model. This evidence concerns the gene C3 and Familial prostate cancer.